Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro
Molecules · 10.04.2026 · 31 (8) · 1257
DOI: 10.3390/molecules31081257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 10.04.2026. Verfasst von Vanja Mališ und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine Foča, University of East Sarajevo, Studentska 5, 73300 Foča, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Neutrophils, Glucose. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of East Sarajevo.
Abstract (Originalsprache)
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat type 2 diabetes. However, several studies have demonstrated its anti-inflammatory and immunomodulatory properties. The aim of this study was to investigate the effect of sitagliptin on the functional and phenotypic properties of human neutrophils under normal (NG, 5.5 mM)- and high (HG, 22 mM)-glucose conditions in vitro. Neutrophils were pretreated with varying concentrations of sitagliptin and stimulated with phorbol-12-myristate-13-acetate (PMA), N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP), calcium ionophore (CaI), or opsonized zymosan (OpZym). Survival, phenotypic, and functional characteristics were then assessed. Our results showed that sitagliptin was non-cytotoxic to neutrophils even at very high concentrations. It decreased the production of reactive oxygen species (ROS) and neutrophil extracellular traps (NETs), generally following a stimulus- and concentration-dependent pattern. The effect was more pronounced under HG conditions. Furthermore, sitagliptin showed a significant ROS-scavenging effect in a cell-free system. It also rapidly altered the expression of surface markers in both resting and fMLP-stimulated neutrophils, typically upregulating CD10, CD16, CD62L, CD63, CD88, CD89, and PD-L1, and downregulating CD11b/CD18, CD66b, and CD182, a phenotype consistent with a dampened, less-primed activation state of these cells. In conclusion, sitagliptin exhibited marked antioxidative/ROS-scavenging activity in neutrophil cultures and induced a coordinated shift in neutrophil phenotype, accompanied by suppression of NETosis under both NG and HG conditions. Collectively, these data support the view that neutrophils may constitute an additional cellular target contributing to sitagliptin’s anti-inflammatory and immunomodulatory profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine Foča, University of East Sarajevo, Studentska 5, 73300 Foča, Bosnia and Herzegovina.
- Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, Crnotravska 27, 11040 Belgrade, Serbia.
- Serbian Academy of Sciences and Arts, Kneza Mihajla 35, 11000 Belgrade, Serbia.
ORCID-Profile: Vanja Mališ, Dušan Mihajlović
Förderung
- University of East Sarajevo
Zitieren
APA
Mališ, V., Drakul, M., Rakočević, S., Kozić, L., Dubovina, A., Popović, D., Bokonjić, D., Mihajlović, D., & Čolić, M. (2026). Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro. Molecules, 31(8), 1257. https://doi.org/10.3390/molecules31081257
Vancouver
Mališ V, Drakul M, Rakočević S, Kozić L, Dubovina A, Popović D, et al. Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro. Molecules. 2026;31(8):1257. doi:10.3390/molecules31081257
BibTeX
@article{Mali2026,
author = {Mališ, Vanja and Drakul, Marija and Rakočević, Sara and Kozić, Ljiljana and Dubovina, Anđela and Popović, Darinka and Bokonjić, Dejan and Mihajlović, Dušan and Čolić, Miodrag},
title = {Sitagliptin Modulates Functional and Phenotypic Properties of Human Neutrophils Under Normal- and High-Glucose Conditions In Vitro},
journal = {Molecules},
year = {2026},
volume = {31},
number = {8},
pages = {1257},
doi = {10.3390/molecules31081257}
}
EUVIMED